2BB score and signals
Rein Therapeutics, Inc.’s current 2BB score is 18 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 20 | Weak |
| Risk | 59 | Moderate |
Company facts
| Headquarters | Austin, Texas, United States |
| Founded | 2001 |
| Employees | 10 |
| 52-week range | $0.69 – $2.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-12 | — | -0.0918 | — | $0.00 |
| 2026-08-12 | — | -0.1734 | — | $0.00 |
| 2026-05-15 | -0.19 | -0.4998 | $0.00 | $0.00 |
| 2026-03-26 | -1.0923 | -0.2193 | $0.00 | $0.00 |
Related companies
